Jorge Gonzalez, MD
Sports Medicine · Fort Lauderdale, FLNPI 1427390137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 32.6% of the total. Reporting peaked in 2019 at $319 and has fallen 73.7% since, to $84 in 2025. That places this record below the midpoint for sports medicine clinicians in FL, where the typical reported total is $1,516.
Across 22 payments — averaging $31.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$227
- Teleflex LLC$75
- Johnson & Johnson$68
- Sonex Health, Inc.$63
- Tenex Health Inc.$47
- Apyx Medical Corporation$39
- plus $179 from 8 others
Across 2 payments — averaging $149,831 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$300K
What the payments were for
- Food & beverage$68598%
- Education$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 3 | $227 |
| Teleflex LLC | 1 | $75 |
| Johnson & Johnson | 3 | $68 |
| Sonex Health, Inc. | 3 | $63 |
| Tenex Health Inc. | 1 | $47 |
| Apyx Medical Corporation | 2 | $39 |
| Curonix LLC | 2 | $36 |
| Nalu Medical, Inc. | 1 | $27 |
| AstraZeneca | 1 | $26 |
| Trice Medical, Inc. | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DALVANCE$107
How this compares
$698 in reported general payments places this provider in the 35th percentile of 402 sports medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 94 | $2,027 |
| Methylprednisolone | 213 | $1,325 |
| Diclofenac Sodium | 448 | $1,024 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $136 |
| Baclofen | 91 | $122 |
| Cyclobenzaprine Hcl | 57 | $89 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $52 |
| Diazepam | 24 | $17 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Fort Lauderdale
- Erol YoldasFort Lauderdale$39K
- Lee KaplanMiami$11.3M
- Patrick SmithNaples$2.9M
- Ryan SimovitchWest Palm Beach$1.1M
- Bruce LevyOrlando$816K
- Gautam YagnikMiami$440K
- Carl DilellaVero Beach$384K
- Adam AnzGulf Breeze$354K
- Stanton LongeneckerJacksonville$330K
- Luga PodestaNaples$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.